
3 More Stocks to Buy Before They Rebound
The Morning Filter
00:00
Earnings Insights: Weight Loss Drugs and Estee Lauder's Struggles
This chapter analyzes the earnings reports of Eli Lilly and Novo Nordisk, highlighting their stock valuations within the growing GLP-1 drug market. It also discusses Estee Lauder's declining stock price and lowered fair value estimates amidst challenges in the Chinese market.
Transcript
Play full episode